Additional information
| Active substance | Lidocaine |
|---|---|
| Water Retention | Minimal to none |
| Hepatotoxicity | Generally low, depends on specific agent and patient condition |
| Lab Test | Specific tests for monitoring blood levels of drugs, e.g., blood concentration levels for Propofol |
| Strength | 10% |
| Also known as | Local anesthetics, general anesthetics, inhalational anesthetics |
| Blood pressure | Can cause decrease in blood pressure |
| Trade name | Various, e.g., Lidocaine as Xylocaine, Propofol as Diprivan, Sevoflurane as Ultane |
| Storage conditions | Depends on specific agent, e.g., room temperature, protect from light |
| Chemical name | Various, including Lidocaine, Propofol, Sevoflurane |
| Formula | Various, e.g., Lidocaine C14H22N2O, Propofol C12H18O, Sevoflurane C4H3F7O |
| Substance class | Anesthetics |
| Main action | Reduces or eliminates sensation, generally by blocking nerve impulses |
| Half-life | Variable, e.g., Lidocaine 1.5-2 hours, Propofol 1-3 hours, Sevoflurane 1-6 minutes |
| Dosage (medical) | Variable, dependent on drug, patient weight, type of anesthesia required, e.g., Lidocaine 1-4.5 mg/kg, Propofol 2-2.5 mg/kg for induction |
| Dosage (sports) | Not applicable |
| Effects | Loss of sensation, unconsciousness, amnesia, muscle relaxation |
| Side effects | Hypotension, respiratory depression, nausea, vomiting, allergic reactions |
| Use in sports | Not typically used in sports due to primary medical application |
| Manufacturer | Universal Life Sciences |
| Packing | 1 bottle/pack |
Plaquenil Sanofi
Champix Starter Pack Pfizer
HALOROW cRowX Labs
ABILIFY 5 mg Bristol - Myers Squibb
Prograf 5mg Astellas Pharma
Fostimon (Merional) 150 IU HMG IBSA
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
PROV-25 INTEX PHARMA
Zyban Glaxosmithkline
Aldactone A Ali Raif Pharma (ARIS)
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Zimaks 400 Bilim
MODAFIN (Provigil) ALPHA PHARMA
Largopen Bilim
PCT INTEX PHARMA
Aldactone Ali Raif Pharma (ARIS) 

Reviews
There are no reviews yet.